Betta Pharmaceuticals Co., Ltd. (SHE:300558)
China · Delayed Price · Currency is CNY 46.15
-2.28 (-4.71%)
Oct 12, 2026, 3:04 PM CST
Betta Pharmaceuticals Market Cap
Betta Pharmaceuticals has a market cap or net worth of 19.42 billion as of October 12, 2026. It is the 5,198th most valuable company in the world and the 861st biggest in China. Its market cap has decreased by 31.99% in one year.
Market Cap
19.42B
Enterprise Value
21.44B
Revenue
3.85B
Global Rank
Country Rank
#861 China
PE Ratio
41.36
ChartMarket Cap Chart
Since November 7, 2016, Betta Pharmaceuticals's market cap has increased from 10.15B to 19.42B, an increase of 91.39%. That is a compound annual growth rate of 6.75%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 12, 2026 | 19.42B | -1.16% |
| Dec 31, 2025 | 19.64B | -12.96% |
| Dec 31, 2024 | 22.57B | 4.62% |
| Dec 29, 2023 | 21.57B | 5.11% |
| Dec 30, 2022 | 20.53B | -38.09% |
| Dec 31, 2021 | 33.15B | -25.26% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Nov 7, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Walvax Biotechnology | 23.59B |
| Jiangsu Nhwa Pharmaceutical Co., LTD | 22.08B |
| Guangdong Zhongsheng Pharmaceutical | 21.66B |
| Tasly Pharmaceutical Group | 21.21B |
| Hybio Pharmaceutical | 20.94B |
| Jilin Aodong Pharmaceutical Group | 20.55B |
| Shanghai Haoyuan Chemexpress | 19.86B |
| Chengdu Kanghong Pharmaceutical Group | 19.03B |